PANT & MEMS chip micro-syringe pump

After the Spring Festival in 2022, Instant Knowledge officially released its first-generation microfluidic MEMS micropump chip HT9207, which has been developed for five years. The HT9207 chip pump integrates precision components such as transducers, actuators, and ultra-light valves on a coin-sized device, supporting microinfusion rates as low as 0.5uL/H and up to 40mL/H, and single infusion Infusion accuracy of 0.5uL±5%.

The animal-grade version of the Instant Knowledge HT9207 chip pump has been officially mass-produced, mainly for wearable animal experimental micro-infusion pump applications, and wearable pet micro-infusion pump applications. It has successfully supported the independent research and development of Instant Knowledge, the world's first. The first-generation wearable microinfusion pump AMP100 product for small animal drug experiments was officially commercialized. The medical-grade version (HT9207M) of Instant Knowledge HT9207 chip pump is expected to achieve small batches in mid-2022 and mass production in the first half of 2024 to support the launch of Instant Knowledge's first-generation patch insulin pump products, and other wearable Human continuous drug delivery pump customer application. "

Instant Knowledge HT9207 chip pump family, in addition to supporting the research and development and mass production of self-owned brand wearable microinfusion pump products, at the same time cooperates with domestic and foreign biomedical and medical device companies to develop MEMS-based micropumps. A complete solution for drug microinfusion, which can be widely used in the treatment of chronic diseases such as Parkinson's disease, heart failure, pain management, etc. At present, it has reached strategic cooperation with a number of biopharmaceutical companies such as Dazhou Biotechnology to promote intelligent controlled release for human use. In-depth cooperation in the field of drug delivery systems.